Skip to main content
Home
  • Main Menu
  • Topics
    • Video
    • Provider
    • Payer
    • Pharma
    • Consumer
    • Investor

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition
Global Edition
Pharma

AstraZeneca, Absci sign $247M agreement to uncover AI-driven cancer drug candidates

The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
By Nathan Eddy
December 06, 2023
02:57 pm
Share

Photo: Zero Creatives GmbH/Getty Images

Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.

The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates optimization of multiple drug features pivotal for therapeutic advantages – and AstraZeneca's oncology research and development knowledge.

The collaboration aims to utilize Absci's de novo "zero-shot" AI models that result in new, improved antibody therapies against cancer.

The "zero-shot" generative AI technique developed by Absci creates antibodies tailored to bind with targets without relying on existing data on antibodies that target those specific markers.

With the capability to screen billions of cells weekly, Absci claims it can progress from AI-designed antibodies to validated candidates within six weeks.

By leveraging this technology, the company hopes to broaden drug target options to encompass previously considered "undruggable" targets, like GPCRs – membrane proteins mediating the cellular response to hormones and ion channels – and boost the potential for successful biologic drug development.

The deal includes an upfront commitment, R&D money, milestone payments and royalties on product sales totaling up to $247 million. 

"AstraZeneca is a leader in developing novel treatments in oncology, and we are excited to collaborate with them to design a therapeutic candidate antibody with the potential to improve the lives of cancer patients,” Sean McClain, Absci founder and CEO, said in a statement. "This agreement advances Absci’s goal of creating a new generation of life-changing and transformative therapeutics using its AI platform."

THE LARGER TREND

Absci recently published a study detailing its zero shot model, and the research results, it says, could "disrupt the shortcomings of the current drug discovery process."

Last month, AstraZeneca announced it formed a new spinoff company, Evinova, which will offer various digital solutions, including an AI-based study design and planning module, to help enhance clinical trials.

The AstraZeneca and Absci partnership follows a November announcement made by German pharma company Boehringer Ingelheim and tech giant IBM to develop AI-based foundational models for antibody treatments to make the process more scalable and efficient. 

Attend Jeremy Petch's sessions at the HIMSS AI in Healthcare Forum taking place on December 14-15, 2023, in San Diego, California. Learn more and register.

Tags: 
Absci, AstraZeneca, drug discovery, AI drug discovery, AI, artificial intelligence

More regional news

Pharmacist interacting online

Serve You Rx, Amazon Pharmacy partner for home delivery

By
Anthony Vecchione
May 02, 2025
Two people shaking hands with six others watch

DarioHealth closes up to $50M debt refinancing and more funding news

By
Jessica Hagen
May 02, 2025
Smart phone and smart watch

Oura and Google Fitbit partner with academia and others to battle opioid disorder

By
Anthony Vecchione
May 02, 2025
Share

Top Story

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder

Editor's Pick

23andMe files for bankruptcy, CEO Wojcicki resigns
Q&A: Oura appoints its first chief medical officer
First blood pressure management system integrated with DeepSeek in Hong Kong
Emirates will offer inflight telemedicine aboard 300 aircraft
Nanowear announces partnership with Dexcom
Navina raises $55M to expand AI for value-based care

More Stories

Pharmacist interacting online
Serve You Rx, Amazon Pharmacy partner for home delivery
Two people shaking hands with six others watch
DarioHealth closes up to $50M debt refinancing and more funding news
Nurse consulting with patient
Teton unveils 3D hospital digital twin using Denmark's supercomputer
Young person communicating with a cell phone
Talkspace, Bark Technologies partner to monitor children's online activities
Pharmacist giving a person an injection
Plenful scores $50M and more funding news
Person interacting with a healthcare professional via tablet
Teladoc acquires UpLift for $30M, releases first quarter results
Person in a pharmacy setting
Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy
Healthcare professional looking at a PC screen
Commure, HealthTap partner for expanded after-hours care
Home

More News

  • Healthcare IT News
  • Healthcare IT News Australia
  • Healthcare Finance News
  • HIMSS TV

MobiHealthNews

 

Connect

Add MobiHealthNews to your network.
HIMSS25 European Health Conference & Exhibition
HIMSS25 European Health Conference & Exhibition
Get ready for knowledge-sharing, all the latest innovations, and in-depth demos with Europe's most influential healthcare community.
10 - 12 June, 2025 | Paris
Learn More
AI in Healthcare Forum
AI in Healthcare Forum
The HIMSS AI in Healthcare Forum cuts through the hype to showcase real-world examples illustrating the transformative potential, and realistic challenges of AI application across the care continuum.
10 - 11 July 2025 | New York
Learn More

Footer Menu

  • About
  • Advertise
  • Reprints
  • Contact
  • Privacy Policy

© 2025 MobiHealthNews is a publication of HIMSS Media

X

Topics

  • Video
  • Provider
  • Payer
  • Pharma
  • Consumer
  • Investor

Career

  • Events
  • Jobs
  • Learning Center

More

  • About
  • Advertise
  • Contact
  • Privacy Policy

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Search form

Top Stories

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder
Three surgeons operating on a patient
Thyroid cancer AI assistant developed in Hong Kong
A doctor discussing findings with an older patient
Digital dementia support project gets $2M federal funding and more briefs